Navigation Links
Avexa Reports Positive Phase IIb Result

und 1.4 million people in North America and around 2.2 million people in Europe have HIV.

Once on therapy, patients with HIV will typically take a minimum of 3 drugs daily in combination. This may increase as a patient progresses into 2nd and 3rd line therapy or into salvage therapy, when patients develop what is commonly referred to as AIDS. Second line patients are defined as patients who show resistance to at least one class of HIV drugs, while 3rd line and salvage patients typically have resistance to multiple drugs and drug classes. Avexa aims to position ATC as the NRTI of choice for treatment of patients in 2nd and 3rd line therapy and salvage therapy, as well as the growing number of treatment naive patients presenting with HIV virus resistant to current front line therapies. In 2005 HIV drugs generated sales globally of USD $6.6 billion, with NRTIs representing greater than 50% of the overall market.

Avexa Limited is a Melbourne-based biotechnology company with a focus on research and development of drugs for the treatment of infectious diseases, in particular diseases which have a significant unmet medical need. Avexa has dedicated resources and funding for key projects including antiviral drugs for HIV and an antibiotic alternative for antibiotic-resistant bacterial infections. The Company's lead program is apricitabine (ATC) which has recently successfully completed the 21 day dosing of its Phase IIb trial. The Company continues to progress ATC towards Phase III trials.

Technical Data

Trial Design

AVX-201 is a randomised, double blind study of two doses of ATC compared to lamivudine (3TC) in treatment-experienced HIV-1 infected patients with the M184V mutation. Patients were randomised to receive 600mg or 800mg ATC twice daily, or 3TC twice daily, for 21 days, in a blinded fashion. The primary endpoint of the study is the change in the amount of virus in the blood (viral load) after 21 days treatment.

After day 2
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Avexas Apricitabine Clinical Trial Update
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Avexa Reports Positive Phase IIb Result
(Date:7/22/2014)... 22, 2014 Sanofi Pasteur, the vaccines division of ... today that the first lots of Fluzone ® (Influenza ... released by the U.S. Food and Drug Administration (FDA) for ... the first of at least 65 million doses of seasonal ... to U.S. health care providers and pharmacies in August. ...
(Date:7/22/2014)... 2014 The Intellectual Property ... the world,s leading provider of intelligent information ... Cortellis Clinical Trials Intelligence , its global ... with the documentation of more than 180,000 ... greater and quicker access to critical data ...
(Date:7/22/2014)... , July 22, 2014 The ... physicians is spreading to previously rep-friendly specialties, according ... sales and marketing consulting firm ZS Associates.      ... than 200 U.S. pharmaceutical sales teams. The report ... prescribers meet with the pharmaceutical sales reps who ...
Breaking Medicine Technology:Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5
... Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in ... overview at the 17th Annual NewsMakers in the Biotech Industry ... at the Millennium Broadway Hotel & Conference Center in New ... will be available on the "Investors & Media" section of ...
... -- Synutra International, Inc. (Nasdaq: SYUT ), ... producer, marketer and seller of nutritional products for infants, ... present at Citi,s Greater China Investor Conference to be ...  Management is currently scheduled to meet with institutional investors ...
Cached Medicine Technology:
(Date:7/22/2014)... (PRWEB) July 22, 2014 DocbookMD ... process of deploying one of the largest physician-centric mobile ... ( MHMD ) in Houston. , Created by Austin-based ... the DocbookMD application will be embedded into MHMD’s Accountable ... searched for the best technology to put this capability ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Air Conditioning ... are now an authorized Daikin comfort pro dealer. This ... Daikin indoor heating and cooling system equipment. Only a ... is thoroughly reviewed before being approved. , Daikin co-developed ... in the Split System Air Conditioning Market. They are ...
(Date:7/22/2014)... United Benefit Advisors (UBA), the nation's leading independent ... insurance veteran with more than 15 years of experience, ... in the company's Chicago office. , UBA Board Chairman ... to accept this important, strategic position with UBA. ... facing UBA and its Partners as we move forward ...
(Date:7/22/2014)... Reinberg HealthDay Reporter TUESDAY, ... during pregnancy may be more likely to have children with ... found that, compared with children born from mothers of normal ... had up to 20 to 30 percent higher odds of ... of pediatrics at Children,s Hospital of Pittsburgh. Forno,s team ...
(Date:7/22/2014)... Plate Club you eat pretty much everything you put ... Cornell University study shows that the average adult eats 92% ... plate. "If you put it on your plate, ... of the forthcoming book, Slim by Design, Professor of Marketing ... Wansink and co-author Katherine Abowd Johnson analyzed 1179 diners and ...
Breaking Medicine News(10 mins):Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 4Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 2Health News:Obesity During Pregnancy Linked to Raised Asthma Risk in Kids 3
... Tips for Days During and ... Following ... there,s smoke,and that,s not good for your respiratory health, cautions experts ... 1902. Residents far beyond the burn areas should monitor their ...
... (October 24, 2007) -- Combat physicians in war-torn areas ... predict which casualties require massive blood transfusions (MT), and ... research published in the October issue of The Journal ... that the presence of a combination of three variables ...
... Waichman Alonso LLP Announces Opening of Dedicated Claims Center To, ... Leads ... The defective Medtronic Sprint,Fidelis Defibrillator Leads were implanted into ... for serious injury if a Sprint Fidelis,Lead fractures. As a ...
... Agree to Fair Union Election Process, ORANGE, Calif., ... Jr., will be among those joining hospital,workers from Mission ... a procession Saturday outside the headquarters of the St. ... a union at SJHS hospitals have,asked the health system,s ...
... , WEDNESDAY, Oct. 24 (HealthDay News) -- British scientists say ... , They said the discovery will prove valuable to scientists ... of the study, published in the Oct. 25 issue of ... a new line of research that eventually enables researchers to ...
... of Smart Choices will provide practical advice in approaching ... a home at the annual meeting of the Institute ... Seattle. , Dr. Ralph L. Keeney, Research Professor of ... University, is co-author of Smart Choices, A Practical Guide ...
Cached Medicine News:Health News:Fire Season: Respiratory Health a Concern 2Health News:Fire Season: Respiratory Health a Concern 3Health News:Early predictive model may be new 'weapon' against leading cause of death on battlefield 2Health News:Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims 2Health News:Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims 3Health News:Trouble deciding? 2Health News:Trouble deciding? 3
... matrix constructed of cross-linked collagen fibers ... through a proprietary 360 accretion process. ... aspirate, Healos provides an excellent environment ... differentiation. The hydroxyapatite-coated collagen microfibers in ...
Sharp Weitlaner Retractor....
Weitlaner retractor, blunt....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
Medicine Products: